Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Kidney International Supplements is Scopus-indexed (Q1, CiteScore 117.7), WoS SCIE. Published by Elsevier B.V..
Checked against the index lists dated .
ISSN 2157-1716Verify ISSN ↗2157-1724Verify ISSN ↗
Publisher: Elsevier B.V.
Cost to publish: About US$3,500 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Nephrology | 1 / 88 | 99th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2024–present (also 2011–2022), best quartile Q1, CiteScore 117.7.
Kidney International Supplements is Q1 in Nephrology (rank 1 of 88), by CiteScore 2025.
Kidney International Supplements is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 117.7, which places it in quartile Q1 at the 99th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 12.369, quartile Q1, with an H-index of 57.
The publisher lists an article processing charge of about US$3,500 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Kidney International Supplements is published by Elsevier B.V. Its print ISSN is 2157-1716 and its online ISSN is 2157-1724.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Kidney International Supplements has an h-index of 69 and a 2-year mean of 6.55 citations per paper (OpenAlex). Its Scopus CiteScore is 117.7, quartile Q1. On 2-year citations it ranks #3 of 87 Scopus journals in Nephrology.
Kidney International Supplements published 5 papers in 2025; its busiest recent year was 2017 with 34. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 47 research articles (2021–2026), authors are most often from United States (36%), Canada (9.2%) and Australia (6.3%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.